কানাডা - ইংরেজি - Health Canada

sun pharma canada inc - clarithromycin - powder for suspension - 250mg - clarithromycin 250mg - other macrolides

কানাডা - ইংরেজি - Health Canada

sun pharma canada inc - clarithromycin - powder for suspension - 125mg - clarithromycin 125mg - other macrolides

কানাডা - ইংরেজি - Health Canada

sun pharma canada inc - clarithromycin - tablet (extended-release) - 500mg - clarithromycin 500mg - other macrolides

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

glaxosmithkline biologicals sa - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (unii: 8c367iy4ey) (bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) - unii:8c367iy4ey), bordetella pertussis pertactin antigen (formaldehyde inactivated) (unii: i05o535nv6) (bordetella pertussis pertactin antigen (formaldehyde inactivated) - unii:i05o535nv6), bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (unii: qsn5xo8zsu) (bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) - unii:qsn5xo8zsu), poliovirus type 1 antigen (formaldehyde inactivated) (unii: 0lvy784c09) (poliovirus type 1 antigen (formaldehyde inactivated) - unii:0lvy784c09), poliovirus type 2 antigen (formaldehyde inactivated) (unii: 23je9kdf4r) (poliovirus type 2 antigen (formaldehyde inactivated) - unii:23je9kdf4r), poliovirus type 3 antigen (formaldehyde inactivated) (unii: 459rom8m9m) (poliovirus type 3 antigen (formaldehyde inactivated) - unii:459rom8m9m) - corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) 25 [iu] in 0.5 ml - a single dose of kinrix is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (dtap) vaccine series and the fourth dose in the inactivated poliovirus vaccine (ipv) series in children aged 4 through 6 years (prior to the seventh birthday) whose previous dtap vaccine doses have been with infanrix (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) and/or pediarix [diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis b (recombinant) and inactivated poliovirus vaccine] for the first 3 doses and infanrix for the fourth dose. severe allergic reaction (e.g., anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, pertussis- or poliovirus-containing vaccine, or to any component of kinrix, including neomycin and polymyxin b, is a contraindication to administration of kinrix [see description (11)] . because of the uncertainty as to which component of the vaccine might be responsible, no further vaccination with any of these components should be given. alternatively, such individuals may be referred to an allergist for evaluation if immunization with any of these components is considered. encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) within 7 days of administration of a previous dose of a pertussis-containing vaccine that is not attributable to another identifiable cause is a contraindication to administration of any pertussis-containing vaccine, including kinrix. progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, or progressive encephalopathy, is a contraindication to administration of any pertussis-containing vaccine, including kinrix. pertussis vaccine should not be administered to individuals with such conditions until a treatment regimen has been established and the condition has stabilized. safety and effectiveness of kinrix in children younger than 4 years and children aged 7 to 16 years have not been evaluated. kinrix is not approved for use in persons in these age groups.

অস্ট্রেলিয়া - ইংরেজি - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - hydroxocobalamin acetate; clostridium chauvoei anaculture; corynebacterium pseudotuberculosis (ovis) anaculture; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal - misc. vaccines or anti sera - hydroxocobalamin acetate vitamin-b12 active 2.0 mg/ml; clostridium chauvoei anaculture vaccine-microbial active 0.3 pcv/ml; corynebacterium pseudotuberculosis (ovis) anaculture vaccine active 0.05 units/ml; clostridium novyi type b - toxoid vaccine-toxoid active 6.0 cpu/ml; clostridium perfringens type d toxoid vaccine-toxoid active 30.0 cpu/ml; clostridium septicum - toxoid vaccine-toxoid active 8.0 cpu/ml; clostridium tetani - toxoid vaccine-toxoid active 3.0 lf/ml; thiomersal mercury other 0.13 mg/ml - immunotherapy

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

blackmores ltd - colecalciferol, quantity: 25 microgram - capsule, soft - excipient ingredients: medium chain triglycerides; lecithin; glycerol; iron oxide red; mixed (low-alpha type) tocopherols concentrate; purified water; soya oil; iron oxide black; gelatin - maintain/support general health and wellbeing ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; maintain/support immune system health ; maintain/support muscle health ; maintain/support muscle function ; maintain/support muscle strength ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

blackmores ltd - colecalciferol, quantity: 25 microgram - capsule, soft - excipient ingredients: gelatin; iron oxide black; iron oxide red; soya oil; glycerol; mixed (low-alpha type) tocopherols concentrate; purified water; medium chain triglycerides; lecithin

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

blackmores ltd - ubidecarenone, quantity: 50 mg - capsule, soft - excipient ingredients: lecithin; sodium chloride; fructose; glycerol; purified water; soya oil; sucrose; gelatin; glucose monohydrate; iron oxide black; sodium sulfite; iron oxide red; yellow beeswax

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

blackmores ltd - magnesium phosphate pentahydrate,manganese amino acid chelate,pyridoxine hydrochloride,retinol acetate,zinc amino acid chelate -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

blackmores ltd - ferrous fumarate, quantity: 15.3 mg (equivalent: iron, qty 5 mg); ascorbic acid, quantity: 100 mg; cyanocobalamin, quantity: 50 microgram; folic acid, quantity: 166.5 microgram; urtica dioica, quantity: 100 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; tapioca starch; microcrystalline cellulose; soy polysaccharide; colloidal anhydrous silica; magnesium stearate; hypromellose; iron oxide red; iron oxide yellow; iron oxide black; titanium dioxide; purified talc; macrogol 8000; macrogol 400; carnauba wax